Keywords: zocor, world, top-selling, drug, merck, co, coronary
Zocor "Will Be World's Top-Selling Drug In 2005"
Article | 13 January 1997
Merck & Co's coronary disease treatment Zocor (simvastatin) will be theworld's top-selling drug in 2005, according to a new study from Datamonitor, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
